You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. NOVEL ASSAY METHODS FOR ETHYLENE GLYCOL TOXICITY

    SBC: MICRONIX, INC.            Topic: N/A

    Not Available Recent discoveries of plant-like organelles in Plasmodium falciparum, the organism that causes malaria, provide potential new avenues toward treatment and prevention of this deadly disease. More specifically, it is now known that the Shikimate Pathway, an enzymatic pathway that provides essential aromatics, is vital to the survival of P. falciparum. By blocking any of the seven enzy ...

    SBIR Phase I 1999 Department of Health and Human Services
  2. Dose Imaging Detectors for Radiotherapy Based on Gas Electron Multipliers

    SBC: PARTTEC, LTD.            Topic: N/A

    DESCRIPTION (provided by applicant): In this SBIR project, PartTec will develop a detector that can support the high precision requirements of Intensity Modulated Proton Therapy, the next-generation Proton Therapy. There are no detectors currently available that meet the design goals of this project, in particular high spatial and timing resolution. While efforts have been started in this area ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  3. PREPARATIVE CHROMATOGRAPHY OF PROTEINS

    SBC: Synchrom Inc.            Topic: N/A

    N/A

    SBIR Phase I 1984 Department of Health and Human Services
  4. SUB-Q ULTRAFILTER/INFUSION DEVICE (SQUID) FOR INSULIN

    SBC: HEMOCLEANSE, INC.            Topic: N/A

    Not Available Painted coatings are not perfect and their integrity is constantly challenged. During everyday use, scratches or scribes are often introduced into a coating. Where this occurs, the underlying metal is exposed directly to the environment and this favors accelerated corrosion. Thus, there is a need for so-called smart coatings that can spontaneously heal themselves wherever they are d ...

    SBIR Phase I 1999 Department of Health and Human Services
  5. Novel VLP Adjuvant based on the VesiVax system

    SBC: Euclid Diagnostics LLC            Topic: NCI

    DESCRIPTION (provided by applicant): Over one million prostate biopsies are performed in the US each year to diagnose approximately 200,000 cases of prostate cancer. The majority of these biopsies are performed needlessly. The overall objective of this project is to develop a secondary prostate cancer diagnostic test that can be performed on men with elevated PSA in order to identify patients in n ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  6. NIEHS- Device Agnostic Environmental/Agent Data Collection and Integration with

    SBC: APEX Therapeuitcs, Inc.            Topic: NCI

    DESCRIPTION (provided by applicant): Our long-term goal is to develop a novel therapeutic strategy for childhood acute lymphoblastic leukemia (ALL), with focus on relapsed T-cell leukemia. We intend to accomplish this by targeting a unique molecular masterregulator using a new generation of compounds. ALL is the most frequent cancer of the childhood. Although significant progress has been achieved ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Identification and Validation of Targets of Phenotypic High Throughput Screening

    SBC: Prosolia, Inc.            Topic: NIGMS

    DESCRIPTION: Development of an Intelligent Sample Introduction System for Mass Spectrometry There is a pressing need for new technologies that enable rapid measurements without significant compromise to the analytical data. Herein, we propose to develop arobust mass spectrometry (MS) based surface sampling device that enables direct analysis of a variety of materials including biological tissue a ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Multi-Functional Guidewire for Peripheral Vasculature

    SBC: 3DT HOLDINGS, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Over 8 million Americans have peripheral vascular disease (PAD). Percutaneous transluminal artery (PTA) treatment of severe PAD involves the use of balloons and stents, but delivery of these therapies is often suboptimal due to inaccuracies in angiographic assessment of vessel size or a lack of proper functional vessel assessment. Additional tools aid clinician ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. Portable device for monitoring water balance in elderly

    SBC: 3DT HOLDINGS, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Transseptal (TS) access for left heart procedures is an important and rapidly growing space for diagnostics and therapy delivery with an expected total of over 10 million U.S. patients. In the U.S. and/or Europe, TS access procedures are used for atrial fibrillation (AF) ablation, left atrial appendage (LAA) closure, patent foramen ovale (PFO) closure, and trea ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. A mechanism-based computational tool to optimize pulmonary drug delivery

    SBC: 3DT HOLDINGS, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Coronary artery disease (CAD) is a national and worldwide epidemic that places the largest clinical and economic burden on the healthcare system of any disease condition. Patients with stable and acute coronary conditions are often treated with percutaneous coronary intervention (PCI), including stenting. Up to 85% of all coronary stents are under-deployed lead ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government